GlassScriptPhysician profile
Sarah Brunner
NPI 1255714499
$7,779.55
in general payments reported to CMS, 2019-2025
21 companies · $1,766 in 2025
The $1,766 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $975 · 2022: $1,216 · 2023: $2,050 · 2024: $1,773 · 2025: $1,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,383 · Education: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,382.66 |
| Education | $206.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,055.62 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Abbvie INC. | $1,277.42 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $876.19 | 2021-2025 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $775.01 | 2021-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $418.02 | 2022-2025 | |
| Galderma Laboratories, L.P. | $411.60 | 2021-2025 | Aklief, Oracea |
| Lilly USA, LLC | $380.54 | 2021-2024 | Taltz, Olumiant, Zepbound |
| Dermavant Sciences, INC. | $242.95 | 2022-2024 | Vtama |
| Ucb, INC. | $224.82 | 2021-2025 | Bimzelx, Cimzia |
| Janssen Scientific Affairs, LLC | $206.64 | 2022 | |
| Amgen INC. | $161.63 | 2023-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $149.06 | 2023-2025 | Sotyktu |
| Organon LLC | $136.20 | 2025 | Vtama |
| Leo Pharma INC. | $129.81 | 2021-2025 | Anzupgo |
| Incyte Corporation | $124.62 | 2021-2024 | Opzelura |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $57.88 | 2021-2022 | |
| Genzyme Corporation | $50.30 | 2023 | |
| Verrica Pharmaceuticals INC. | $36.56 | 2023-2025 | Ycanth |
| Pfizer INC. | $28.34 | 2023 | |
| Botanix Sb INC | $22.62 | 2025 | Sofdra |
| Arcutis Biotherapeutics, INC. | $13.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Brunner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.